1.
Checkley S. The neuroendocrinology of depression and chronic stress.
Br Med Bull. 1996;52:597-617.
Checkley S.. The neuroendocrinology of depression and chronic stress. (Br Med Bull):1996;52:597-617. PMID:
10.1093/oxfordjournals.bmb.a011570.
2.
Keck ME. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.
Amino Acids. 2006; 31:241-50.
. Keck ME.. Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety.
Amino Acids 2006;31:241-50. PMID:
10.1007/s00726-006-0333-y. PMID:
16733617.
3.
Herman JP, McKlveen JM, Solomon MB, Carvalho-Netto E, Myers B. Neural regulation of the stress response: glucocorticoid feedback mechanisms.
Braz J Med Biol Res. 2012;45: 292-8.
Herman JP., McKlveen JM., Solomon MB., Carvalho-Netto E., Myers B.. Neural regulation of the stress response: glucocorticoid feedback mechanisms.
Braz J Med Biol Res 2012;45:292-298. PMID:
10.1590/S0100-879X2012007500041. PMID:
22450375.
4.
Holsboer F, Barden N. Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation.
Endocr Rev.. 1996; 17:187-205.
. Holsboer F., Barden N.. Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation.
Endocr Rev. 1996;17:187-205. PMID:
10.1210/edrv-17-2-187. PMID:
8706631.
5.
Droste SK, Schweizer MC, Ulbricht S, Reul JMHM. Long-Term Voluntary Exercise and the Mouse Hypothalamic-Pituitary-Adrenocortical Axis: Impact of Concurrent Treatment with the Antidepressant Drug Tianeptine.
J Neuroendocrinol.. 2006;18:915-925.
. Droste SK., Schweizer MC., Ulbricht S., Reul JMHM.. Long-Term Voluntary Exercise and the Mouse Hypothalamic-Pituitary-Adrenocortical Axis: Impact of Concurrent Treatment with the Antidepressant Drug Tianeptine.
J Neuroendocrinol 2006;18:915-925. PMID:
10.1111/j.1365-2826.2006.01489.x. PMID:
17076767.
6.
Van Praag HM. Depression, suicide and the metabolism of serotonin in the brain.
J Affect Disord. 1982;4: 275-90.
. Van Praag HM.. Depression, suicide and the metabolism of serotonin in the brain.
J Affect Disord 1982;4:275-90. PMID:
10.1016/0165-0327(82)90025-8. PMID:
6186712.
7.
Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD. Basic Neurochemistry, 6th edition. American Society for Neurochemistry. 1999.
Siegel GJ., Agranoff BW., Albers RW., Fisher SK., Uhler MD.Basic Neurochemistry. 6th edition. American Society for Neurochemistry. 1999.
8.
Hariri AR, Weinberger DR. Functional neuroimaging of genetic variation in serotonergic neurotransmission.
Genes Brain Behav. 2003;2:341-9.
. Hariri AR., Weinberger DR.. Functional neuroimaging of genetic variation in serotonergic neurotransmission.
Genes Brain Behav 2003;2:341-9. PMID:
10.1046/j.1601-1848.2003.00048.x. PMID:
14653306.
9.
Girbig D, Keller K, Prelle K, Patchev V, Vonk R, Igl B-W. A dynamic model of circadian rhythms in rodent tail skin temperature for comparison of drug effects.
J Circadian Rhythms. 2012;10:1
. Girbig D., Keller K., Prelle K., Patchev V., Vonk R., Igl B-W.. A dynamic model of circadian rhythms in rodent tail skin temperature for comparison of drug effects.
J Circadian Rhythms 2012;10:1PMID:
10.1186/1740-3391-10-1. PMID:
22221596.
10.
Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: A new model sensitive to antidepressant treatments.
Eur J Pharmacol. 1978;47:379-91.
. Porsolt RD., Anton G., Blavet N., Jalfre M.. Behavioural despair in rats: A new model sensitive to antidepressant treatments.
Eur J Pharmacol 1978;47:379-91. PMID:
10.1016/0014-2999(78)90118-8. PMID:
204499.
11.
Daniel Santarsieri TLS. Antidepressant efficacy and side-effect burden: a quick guide for clinicians.
Drugs in Context. 2015;4:1-12.
. Daniel Santarsieri TLS.. Antidepressant efficacy and side-effect burden: a quick guide for clinicians.
Drugs in Context 2015;4:1-12. PMID:
10.7573/dic.212290.
12.
Renoir T, Pang TY, Zajac MS, Chan G, Du X, Leang L, Chevarin C, Lanfumey L, Hannan AJ. Treatment of depressive-like behaviour in Huntington’s disease mice by chronic sertraline and exercise.
Br J Pharmacol. 2012;165:1375-89.
Renoir T., Pang TY., Zajac MS., Chan G., Du X., Leang L., Chevarin C., Lanfumey L., Hannan AJ.. Treatment of depressive-like behaviour in Huntington’s disease mice by chronic sertraline and exercise.
British Journal of Pharmacology 2012;165:1375-1389. PMID:
10.1111/j.1476-5381.2011.01567.x. PMID:
21718306.
13.
Trivedi MH, Greer TL, Church TS, Carmody TJ, Grannemann BD, Galper DI, Dunn AL, Earnest CP, Sunderajan P, Henley SS, Blair SN. Exercise as an augmentation treatment for onremitted major depressive disorder: a randomized, parallel dose comparison. J Clin Psychiatry. 2011;72:677-84.
Trivedi MH., Greer TL., Church TS., Carmody TJ., Grannemann BD., Galper DI., Dunn AL., Earnest CP., Sunderajan P., Henley SS., Blair SN.. Exercise as an augmentation treatment for onremitted major depressive disorder: a randomized, parallel dose comparison.
J Clin Psychiatry 2011;72:677-684. PMID:
10.4088/JCP.10m06743. PMID:
21658349.
14.
Stolk JM, Barchas JD, Goldstein M, Boggan W, Freedman DX. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism. J Pharmacol Exp Ther. 1974;189: 42-50.
Stolk JM., Barchas JD., Goldstein M., Boggan W., Freedman DX.. A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism.
J Pharmacol Exp Ther 1974;189:42-50. PMID:
4823298.
15.
Elias AN, Iyer K, Pandian MR, Weathersbee P, Stone S, Tobis J. Beta-Endorphin Beta-Lipotropin Release and Gonadotropin-Secretion After Acute Exercise in Normal Males.
J Appl Physiol. 1986;61:2045-9.
. Elias AN., Iyer K., Pandian MR., Weathersbee P., Stone S., Tobis J.. Beta-Endorphin Beta-Lipotropin Release and Gonadotropin-Secretion After Acute Exercise in Normal Males.
J Appl Physiol 1986;61:2045-9. PMID:
2948941.
16.
Zheng H, Liu Y, Li W, Yang B, Chen D, Wang X, Jiang Z, Wang H, Wang Z, Cornelisson G, Halberg F. Beneficial effects of exercise and its molecular mechanisms on depression in rats.
Behavioural Brain Research. 2006;168:47-55.
Zheng H., Liu Y., Li W., Yang B., Chen D., Wang X., Jiang Z., Wang H., Wang Z., Cornelisson G., Halberg F.. Beneficial effects of exercise and its molecular mechanisms on depression in rats.
Behavioural Brain Research 2006;168:47-55. PMID:
10.1016/j.bbr.2005.10.007. PMID:
16290283.
17.
Goldfarb DAH, Jamurtas AZ. β-Endorphin Response to Exercise.
Sports Med. 1997;24:8-16.
. Goldfarb DAH., Jamurtas AZ.. β-Endorphin Response to Exercise.
Sports Med 1997;24:8-16. PMID:
10.2165/00007256-199724010-00002. PMID:
9257407.
18.
Solberg LC, Horton TH, Turek FW. Circadian rhythms and depression: effects of exercise in an animal model.
Am J Physiol Regul Integr Comp Physiol. 1999;276:R152-R161.
. Solberg LC., Horton TH., Turek FW.. Circadian rhythms and depression: effects of exercise in an animal model.
Am J Physiol Regul Integr Comp Physiol 1999;276:R152-61.
19.
Binder E, Droste SK, Ohl F, Reul JMHM. Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice.
Behav Brain Res. 2004;155:197-206.
. Binder E., Droste SK., Ohl F., Reul JMHM.. Regular voluntary exercise reduces anxiety-related behaviour and impulsiveness in mice.
Behav Brain Res 2004;155:197-206. PMID:
10.1016/j.bbr.2004.04.017. PMID:
15364478.
20.
Lee KS, Shin HS, Kim CJ. The Effects of intensity of treadmill exercise and duration of mild-treadmill exercise on serotonin activity in rat brain. J Exerc Nutrition Biochem. 2004;8:57-63.
. Lee KS., Shin HS., Kim CJ.. The Effects of intensity of treadmill exercise and duration of mild-treadmill exercise on serotonin activity in rat brain.
J Exerc Nutrition Biochem 2004;8:57-63.
21.
Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, Craighead WE, Baldewicz TT, Krishnan KR. Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months.
Psychosom Med. 2000;62:633-8.
Babyak M., Blumenthal JA., Herman S., Khatri P., Doraiswamy M., Moore K., Craighead WE., Baldewicz TT., Krishnan KR.. Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months.
Psychosom Med 2000;62:633-8. PMID:
10.1097/00006842-200009000-00006. PMID:
11020092.
22.
Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?
Neuroscience. 2002;112:243-60.
. Wyss M., Schulze A.. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?
Neuroscience 2002;112:243-60. PMID:
10.1016/S0306-4522(02)00088-X. PMID:
12044443.
23.
Benzi G. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?
Pharmacol Res. 2000;41:255-64.
. Benzi G.. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?
Pharmacol Res 2000;41:255-64. PMID:
10675277.
24.
Juhn MS, Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review.
Clin J Sport Med. 1998;8:286-97.
. Juhn MS., Tarnopolsky M.. Oral creatine supplementation and athletic performance: a critical review.
Clin J Sport Med 1998;8:286-97. PMID:
10.1097/00042752-199810000-00006. PMID:
9884793.
25.
Maughan RJ, King DS, Lea T. Dietary supplements.
J Sports Sci. 2007;22:95-113.
. Maughan RJ., King DS., Lea T.. Dietary supplements.
J Sports Sci 2007;22:95-113. PMID:
10.1080/0264041031000140581.
26.
Williams MH, Branch JD. Creatine Supplementation and Exercise Performance: An Update.
J Am Coll Nutr. 2013;17:216-34.
. Williams MH., Branch JD.. Creatine Supplementation and Exercise Performance: An Update.
J Am Coll Nutr 2013;17:216-34. PMID:
10.1080/07315724.1998.10718751.
27.
Rawson ES, Volek JS. Effects of Creatine Supplementation and Resistance Training on Muscle Strength and Weightlifting Performance.
J Strength Cond Res. 2003;17:822-31.
Rawson ES., Volek JS.. Effects of Creatine Supplementation and Resistance Training on Muscle Strength and Weightlifting Performance.
J Strength Cond Res 2003;17:822-31. PMID:
10.1519/00124278-200311000-00031. PMID:
14636102.
28.
Rae C, Digney AL, McEwan SR. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial.
Proc Biol Sci. 2003; 22:270:2147-50.
. Rae C., Digney AL., McEwan SR.. Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial.
Proc Biol Sci 2003;22 270:2147-50. PMID:
10.1098/rspb.2003.2492. PMID:
14561278.
29.
Allen PJ, D’Anci KE, Kanarek RB, Renshaw PF. Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.
Pharmacol Biochem Behav. 2012;101:588-601.
. Allen PJ., D’Anci KE., Kanarek RB., Renshaw PF.. Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.
Pharmacol Biochem Behav 2012;101:588-601. PMID:
10.1016/j.pbb.2012.03.005. PMID:
22429992.
30.
Cunha MP, Machado DG, Capra JC, Jacinto J, Bettio LE, Rodrigues ALS. Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol (Oxford). 2012;26:1489-501.
. Cunha MP., Machado DG., Capra JC., Jacinto J., Bettio LE., Rodrigues ALS.. Antidepressant-like effect of creatine in mice involves dopaminergic activation. J Psychopharmacol (Oxford) 2012;26:1489-501. PMID:
10.1177/0269881112447989. PMID:
22674968.
31.
Allen PJ, D’Anci KE, Kanarek RB, Renshaw PF. Chronic Creatine Supplementation Alters Depression-like Behavior in Rodents in a Sex-Dependent Manner.
Neuropsychopharmacology. 2009;35:534-546.
. Allen PJ., D’Anci KE., Kanarek RB., Renshaw PF.. Chronic Creatine Supplementation Alters Depression-like Behavior in Rodents in a Sex-Dependent Manner.
Neuropsychopharmacology 2009;35:534-546. PMID:
10.1038/npp.2009.160.
32.
Roitman S, Green T, Osher Y, Karni N, Levine J. Creatine monohydrate in resistant depression: a preliminary study.
Bipolar Disord. 2007;9:754-8.
. Roitman S., Green T., Osher Y., Karni N., Levine J.. Creatine monohydrate in resistant depression: a preliminary study.
Bipolar Disord 2007;9:754-8. PMID:
10.1111/j.1399-5618.2007.00532.x. PMID:
17988366.
33.
Lyoo IK, Yoon S, Kim TS, Hwang J. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
Am J Psychiatry. 2012;169:937-45.
. Lyoo IK., Yoon S., Kim TS., Hwang J.. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
Am J Psychiatry 2012;169:937-45. PMID:
10.1176/appi.ajp.2012.12010009. PMID:
22864465.
34.
Ito S, Nitta Y, Fukumitsu H, Soumiya H, Ikeno K, Nakamura T, Furukawa S. Antidepressant-Like Activity of 10-Hydroxy-Trans-2-Decenoic Acid, a Unique Unsaturated Fatty Acid of Royal Jelly, in Stress-Inducible Depression-Like Mouse Model.
Evid Based Complement Alternat Med. 2011;2012:1-6.
Ito S., Nitta Y., Fukumitsu H., Soumiya H., Ikeno K., Nakamura T., Furukawa S.. Antidepressant-Like Activity of 10-Hydroxy-Trans-2-Decenoic Acid, a Unique Unsaturated Fatty Acid of Royal Jelly, in Stress-Inducible Depression-Like Mouse Model.
Evid Based Complement Alternat Med 2011;2012:1-6. PMID:
10.1155/2012/139140.
35.
Chang H, Saito T, Ohiwa N, Tateoka M, Deocaris CC, Fujikawa T, Soya H. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats.
Neurosci Res. 2007;57:462-6.
Chang H., Saito T., Ohiwa N., Tateoka M., Deocaris CC., Fujikawa T., Soya H.. Inhibitory effects of an orexin-2 receptor antagonist on orexin A- and stress-induced ACTH responses in conscious rats.
Neurosci Res 2007;57:462-6. PMID:
10.1016/j.neures.2006.11.009. PMID:
17188385.
36.
Ito N, Nagai T, Yabe T, Nunome S, Hanawa T, Yamada H. Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis. Phytomedicine. 2006;13(9-10):658.
Ito N., Nagai T., Yabe T., Nunome S., Hanawa T., Yamada H.. Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis.
Phytomedicine 2006;13(9-10):658PMID:
10.1016/j.phymed.2006.01.002. PMID:
16516452.
37.
Kim KS, Han PL. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters.
J Neurosci Res. 2006;83:497-507.
. Kim KS., Han PL.. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters.
J Neurosci Res 2006;83:497-507. PMID:
10.1002/jnr.20754. PMID:
16416425.
38.
Bender A, Beckers J, Schneider I, Hölter SM, Haack T, Ruthsatz T, Vogt-Weisenhorn DM, Becker L, Genius J, Rujescu D, Irmler M, Mijalski T, Mader M, Quintanilla-Martinez L, Fuchs H, Gailus-Durner V, de Angelis MH, Wurst W, Schmidt J, Klopstock T. Creatine improves health and survival of mice.
Neurobiol Aging. 2008;29:1404-1411.
Bender A., Beckers J., Schneider I., Hölter SM., Haack T., Ruthsatz T., Vogt-Weisenhorn DM., Becker L., Genius J., Rujescu D., Irmler M., Mijalski T, Mader M., Quintanilla-Martinez L., Fuchs H, Gailus-Durner V., de Angelis MH., Wurst W., Schmidt J., Klopstock T.. Creatine improves health and survival of mice.
Neurobiol Aging 2008;29:1404-1411. PMID:
10.1016/j.neurobiolaging.2007.03.001. PMID:
17416441.
39.
Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF. Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease.
J Neurosci. 2000;20:4389-4397.
Ferrante RJ., Andreassen OA., Jenkins BG., Dedeoglu A., Kuemmerle S., Kubilus JK., Kaddurah-Daouk R, Hersch SM., Beal MF. Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease.
J Neurosci 2000;20:4389-4397. PMID:
10844007.
40.
Dishman RK, Buckworth J. Increasing physical activity: a quantitative synthesis.
Med Sci Sports Exerc. 1996;28:706-19.
Dishman RK., Buckworth J.. Increasing physical activity: a quantitative synthesis.
Med Sci Sports Exerc 1996;28:706-19. PMID:
10.1097/00005768-199606000-00010. PMID:
8784759.
41.
Ströhle A. Physical activity, exercise, depression and anxiety disorders.
J Neural Transm. 2009;116:777-84.
. Ströhle A.. Physical activity, exercise, depression and anxiety disorders.
J Neural Transm 2009;116:777-84. PMID:
10.1007/s00702-008-0092-x. PMID:
18726137.
42.
Veale D, Le Fevre K, Pantelis C, de Souza V, Mann A, Sargeant A. Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial.
J R Soc Med. 1992;85:541-4.
. Veale D., Le Fevre K., Pantelis C., de Souza V., Mann A., Sargeant A.. Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial.
J R Soc Med 1992;85:541-4. PMID:
1433121.
43.
Conroy RW, Smith K, Felthous AR. The Value of Exercise on a Psychiatric Hospital Unit.
Psychiatr Serv. 2006;33:641-5.
. Conroy RW., Smith K., Felthous AR.. The Value of Exercise on a Psychiatric Hospital Unit.
Psychiatr Serv 2006;33:641-5. PMID:
10.1176/ps.33.8.641.
44.
Burghardt PR, Fulk LJ, Hand GA, Wilson MA. The effects of chronic treadmill and wheel running on behavior in rats.
Brain Res. 2004;1019:84-96.
. Burghardt PR., Fulk LJ., Hand GA., Wilson MA.. The effects of chronic treadmill and wheel running on behavior in rats.
Brain Res 2004;1019:84-96. PMID:
10.1016/j.brainres.2004.05.086. PMID:
15306242.
45.
Bambico FR, Nguyen N-T, Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress.
Eur Neuropsychopharmacol. 2009;19:215-28.
. Bambico FR., Nguyen N-T., Gobbi G.. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress.
Eur Neuropsychopharmacol 2009;19:215-28. PMID:
10.1016/j.euroneuro.2008.11.005. PMID:
19147333.
46.
Otsuka T, Nishii A, Amemiya S, Kubota N, Nishijima T, Kita I. Effects of acute treadmill running at different intensities on activities of serotonin and corticotropin-releasing factor neurons, and anxiety- and depressive-like behaviors in rats.
Behav Brain Res. 2015;298:44-51.
. Otsuka T., Nishii A., Amemiya S., Kubota N., Nishijima T., Kita I.. Effects of acute treadmill running at different intensities on activities of serotonin and corticotropin-releasing factor neurons, and anxiety- and depressive-like behaviors in rats.
Behav Brain Res 2015;298:44-51. PMID:
10.1016/j.bbr.2015.10.055. PMID:
26542811.
47.
Chaouloff F. Physical exercise and brain monoamines: a review.
Acta Physiol Scand. 1989;137:1-13.
Chaouloff F.. Physical exercise and brain monoamines: A review.
Acta Physiol Scand 1989;137:1-13. PMID:
10.1111/j.1748-1716.1989.tb08715.x. PMID:
2678895.
48.
Trulson ME, Preussler DW, Trulson VM. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats. J Pharmacol Exp Ther. 1984;228:94-102.
. Trulson ME., Preussler DW., Trulson VM.. Differential effects of hallucinogenic drugs on the activity of serotonin-containing neurons in the nucleus centralis superior and nucleus raphe pallidus in freely moving cats.
J Pharmacol Exp Ther 1984;228:94-102. PMID:
6694110.
49.
Zalpuri I, Rothschild AJ. Does psychosis increase the risk of suicide in patients with major depression? A systematic review.
J Affect Disord. 2016;198:23-31.
. Zalpuri I., Rothschild AJ.. Does psychosis increase the risk of suicide in patients with major depression? A systematic review.
J Affect Disord 2016;198:23-31. PMID:
10.1016/j.jad.2016.03.035. PMID:
26998793.
50.
Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system.
Brain Res Bull. 2008;76:329-43.
. Andres RH., Ducray AD., Schlattner U., Wallimann T., Widmer HR.. Functions and effects of creatine in the central nervous system.
Brain Res Bull 2008;76:329-43. PMID:
10.1016/j.brainresbull.2008.02.035. PMID:
18502307.
51.
Adhihetty PJ, Beal MF. Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases.
Neuromol Med. 2008;10:275-90.
Adhihetty PJ., Beal MF.. Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases.
Neuromol Med 2008;10:275-90. PMID:
10.1007/s12017-008-8053-y.